CareFusion AirLife Signs New Distribution Agreement with ResMed

In ICU
Thu, 5 Nov 2015

AirLife to Offer Nasal High Flow Interfaces from ResMed

CareFusion, a BD company (NYSE:BDX), announced its AirLife business line has signed an exclusive agreement with ResMed (NYSE:RMD) to distribute innovative nasal high flow interface products from the company.

"This agreement with ResMed is aligned with our commitment to providing high quality respiratory products to our customers," said Dan Woolson, president of Respiratory Solutions at BD. "This collaboration will help ensure our customers have access to a full portfolio of leading respiratory solutions."

The agreement with ResMed includes exclusive distribution rights for its AcuCare™ high flow nasal cannula in the U.S. acute care market. ResMed's nasal cannula offers a fast and intuitive fit, and is engineered to stay in place once fitted, providing speed and stability for built-in success in high flow oxygen therapy.

"The combination of ResMed products with AirLife's reach will help provide more patients with innovative respiratory technology," said Jim Hollingshead, president ResMed Americas. "This collaboration helps position ResMed for growth beyond what we could achieve alone."

Additional terms of the agreement were not disclosed.

Source & Image Credit : CareFusion

«« Apgar Score May Relate to Mother's Risk of Critical Illness

Accurately Setting PEEP with Transpulmonary Pressure »»

Respiratory, CareFusion, BD, ResMed

Latest Articles

Decision-Making in the ICU
- ICU Journal Article
- 19/04/2024
Decision-making in the ICU is a multifaceted process that involves clinical assessment, collaboration among multidisciplinary teams, ethical considerations, evidence-based practice, communication, and continuous adaptation to evolving clinical scenarios. Balancing the complex factors requires
READ MORE
Dealing With Uncertainty in ICU Decision-Making: A Practical Guide
- ICU Journal Article
- 19/04/2024
When the stakes are high, and the path ahead is uncertain, the decisions made, especially if a patient continues to worsen, can be sources of self-torment and can haunt us for a long time. Our goal is to suggest ways to steer decision-making for intensivists in the face of uncertainty by prop
READ MORE
The Least Bad Decision: Crisis Standards of Care After the Pandemic
- ICU Journal Article
- 19/04/2024
COVID-19 was an emergency that lasted for years and left few regions of the world untouched. The pandemic shone a spotlight on both the strengths and weaknesses of our disaster planning. What worked, what did not, and how can we better plan for future emergencies? The COVID-19 pandemic fo
READ MORE

CareFusion, Respiratory Products, ResMed, Air Life CareFusion, a BD company (NYSE:BDX), announced its AirLife business line has signed an exclusive agreement with ResMed (NYSE:RMD) to distribute innovative nasal high flow interface products from the company.